Best Life Sciences Companies in Miami, United States
The 106 best Life Sciences companies in Miami, United States in 2026, ranked by funding and momentum. Funding, investors, founders, valuation, tech stack and live signals. Top: Neocis.
Our analysis of 164 Life Sciences companies
$34.7b in tracked funding; 83% of the stack-profiled cohort runs cloud-native; funding activity peaked in 2025.
Ranked: Best Life Sciences companies in Miami
| # | Company | Disclosed funding | Last round | Stage | Employees | Founder | Tech stack | Patents & IP focus | Recent signals |
|---|---|---|---|---|---|---|---|---|---|
| 1 | Neocis Provider of robotic guidance system for dental surgeries 74Innovation top 16%Patents top 17%Funding top 25%Moat top 26% All 10 signals ▾Innovationtop 16% Patentstop 17% Fundingtop 25% Moattop 26% Growthtop 33% Techtop 40% Markettop 48% Talentbottom 49% Globalbottom 42% Newsbottom 22% Innovation: 198 patents (top 8% of patent-holders) · 117 filings since 2022 vs 64 in 2017-21 Patents: 198 patents matched (strict assignee match) · 117 filings since 2022 vs 64 in 2017-21 rank vs industry peers · Fliar Intelligence Index 74/100 | $179M | 29 mo ago | Series D | 118 118 → 113 (-4%) | Alon Mozes Co-Founder & CEO | Cart FunctionalityWooCommerceWordPress+44 | 198 patents Robotic-guided dental and cranio‑maxillofacial surgery systems and planning tools | 1 launch · 1 award |
| 2 | BioTissue Developer of regenerative biologic therapies for eye care | $110M | 60 mo ago | Series C | 234 234 → 372 (+59%) | Amy Tseng Founder and Board Member | Cart FunctionalityWordPressApple iCloud Mail+27 | 31 patents Patents concentrated in health & consumer products | 1 job opening |
| 3 | DermaSensor Developer of an AI-powered skin cancer detection device 64Funding top 25%News top 29%Innovation top 35%Growth top 35% All 12 signals ▾Fundingtop 25% Newstop 29% Innovationtop 35% Growthtop 35% AItop 35% Producttop 35% Moattop 37% Techtop 38% Patentstop 42% Talentbottom 49% Marketbottom 34% Globalbottom 33% Funding: Raised $35.8M across 6 rounds · 6 rounds over 8 yrs (0.8/yr) News: 3 BI events in 12 mo (of 7 tracked, 3 types) · Top themes: Funding, Capital raise rank vs industry peers · Fliar Intelligence Index 64/100 | $36M | 8 mo ago | Series B | 24 | Cody Simmons CEO | WordPressBetterDocsSentry+46 | 10 patents Non‑invasive optical spectroscopy for melanoma and skin cancer detection | — |
| 4 | CLS Holdings USA Manufacturer specialising in products extracted from cannabis | $35M | 90 mo ago | Public | 78 | Jeffrey Binder Chairman & CEO | — | — | — |
| 5 | Rational Vaccines Developer of live attenuated viral immunotherapeutic and prophylactic vaccine candidates 29Funding top 28%Moat top 38%Patents top 40%Innovation top 46% All 8 signals ▾Fundingtop 28% Moattop 38% Patentstop 40% Innovationtop 46% Talentbottom 49% Techbottom 42% Globalbottom 37% Marketbottom 25% Funding: Raised $30.6M across 12 rounds · 12 rounds over 11 yrs (1.1/yr) Moat: Editorial + unicorn rating 4/10 · IP moat: 9 patents rank vs industry peers · Fliar Intelligence Index 29/100 | $31M | 8 mo ago | Series B | 18 18 → 11 (-39%) | Agustin Fernandez Founder & CEO | WordPressMySQLPHP+17 | 9 patents Serological SARS‑CoV‑2 diagnostics and recombinant vaccine platforms for intracellular pathogens. | — |
| 6 | Med-tek Dynamic neuromuscular assessment tool and other soft tissue diagnostic systems | $15M | 135 mo ago | Series A | 1 | Kerwin Williams ex-President & CEO | — | — | — |
| 7 | Stem Synergy Biotechnology company discovering novel cancer therapeutics targeting fundamental mechanisms | $14M | 50 mo ago | Funding Raised | 8 | Anthony Capobianco Co-Founder | — | — | — |
| 8 | NAVIGANTIS Developer of a surgical device for treatment | $12M | 25 mo ago | Series A | — | Hyosig Kang Co-Founder | CTO at NAVIGANTIS Inc | WixSentryBootstrap+10 | — | — |
| 9 | Guard Medical Developer of smart wound dressing products for wound care | $11M | 50 mo ago | Series B | 9 | Laurence Lefebvre Co-Founder & COO | — | — | — |
| 10 | ADvantage Therapeutics Developer of immunotherapies for neurological disorders | $10M | 35 mo ago | Series B | 2 | Jeffrey Madden CEO | — | — | — |
| 11 | Metallomix Developer of metal-based therapies to treat neurological disorders | $10M | 33 mo ago | Seed | — | Santosh Kesari Co-Founder | — | — | — |
| 12 | Syntheon Innovating medical care through technology, patents, and enduring partnerships | $10M | 98 mo ago | Series A | 35 | Matt Palmer Co-Founder & CTO | — | 138 patents Percutaneous left atrial appendage clipping devices and aspiration thrombectomy catheters for cardiac interventions | — |
| 13 | SafeStitch Portfolio of products for Gastrointestinal, and Bariatric surgery | $8M | 153 mo ago | Public | 167 | — | — | 2 patents Provides mobile hospital beds for patient transport and care. | — |
| 14 | Aegle Therapeutics Developing extracellular vesicle therapies for debilitating rare diseases and dermatological disorders | $6M | 5 mo ago | Series A | 4 | — | WordPressMySQLPHP+16 | — | — |
| 15 | Ambulero Developer of cell & gene therapies for the treatment of rare vascular disease and critical limb ischemia | $6M | 36 mo ago | Seed | 5 | Robert Buchanan Co-founder | — | — | — |
| 16 | DemeRx Developer of non-addicting alternatives for opioid de-addiction | $5M | 133 mo ago | Series A | 4 | Deborah Mash Founder & CEO | WordPressApple iCloud MailMySQL+15 | 296 patents Ibogaine-derived compounds for opioid addiction and withdrawal therapy | — |
| 17 | SwiftSync Developer of a medical device for temporary A-V sequential pacing catheter | $5M | 28 mo ago | Series A | 3 | Eduardo DeMarchena Co-Founder | — | — | — |
| 18 | Nutrition Corporation Plant-based nutrition for simplified, vibrant living and achieving wellness goals | $4M | 114 mo ago | Series A | 3 | Marco Borges CEO & Founder | Cart FunctionalityShopifyBootstrap+40 | 151 patents Formulating silicon, biotin, and chromium dietary supplements and microbial cell bleaching technologies. | — |
| 19 | Kiala Online retailer of nutritional supplements formulated for women's health needs | $3M | 4 mo ago | Funding Raised | — | Pete Christel Co-Founder & Co-Owner | Cart FunctionalityShopifySentry+29 | — | — |
| 20 | Miami Instruments Develops surgical instruments used in minimally invasive cardiac surgeries | $3M | 175 mo ago | Seed | — | Joseph Lamelas CEO | — | — | — |
| 21 | Regentys Developer of regenerative medicines for gastrointestinal disorders | $3M | 115 mo ago | Acquired | 4 | Marc Ramer Co-Founder | — | 19 patents Biologic therapies and extracellular matrix scaffolds for inflammatory bowel disease treatment | — |
| 22 | Genetic Networks Accelerating drug development through modular biology and whole-genome analysis | $2M | 83 mo ago | Acquired | 11 | Gennaro D'urso Founder and Chairman | — | — | — |
| 23 | Everglades Biopharma Developing ligand-based therapies for neovascular diseases and cancer | $2M | 15 mo ago | Funding Raised | — | Nile Bank Co-Founder | — | — | — |
| 24 | Source Molecular Provider of technology for microbial source tracking | $2M | 107 mo ago | Acquired | 13 | — | — | — | — |
| 25 | Strauss Surgical Innovating minimally invasive surgical solutions with high-definition endoscopes and instruments | $2M | 25 mo ago | Seed | — | — | — | — | 2 launchs |
| 26 | Quthero Developer of a patented gel platform technology for wound management | $1M | 27 mo ago | Seed | 3 | Milica Radisic Co-Founder | — | 7 patents Peptide‑hydrogel formulations for skin therapy and immune‑modulating wound care | — |
| 27 | Vector Vitale Developer of bio-molecule-based therapeutics for the treatment of oncology and other degenerative diseases | $1M | 49 mo ago | Seed | 4 | Victor Vedovato Managing Director | — | 103 patents Anti‑aging nutraceuticals and pharma compositions targeting homeostasis, inflammation, and viral defense | — |
| 28 | Longeveron Developer of cellular therapies for aging-related and life-threatening conditions | $1M | 3 mo ago | Public | 23 23 → 41 (+78%) | Joshua Hare Co-Founder | WordPressMySQLPHP+18 | 38 patents Mesenchymal stem cell therapeutics and potency assays for neurodegenerative and sexual health | 1 job opening |
| 29 | RxMP Therapeutics Developer of RBC-derived microparticles to arrest or prevent excessive bleeding | $1M | 62 mo ago | Seed | — | Rifat Pamukcu CEO & President | — | — | — |
| 30 | TissueLabs Provider of a platform for creating organs and tissues in the lab | $800K | 27 mo ago | Seed | 13 | — | Wix eCommerceWixSentry+22 | — | 1 partnership |
| 31 | Binder Biomedical Intervertebral Body Fusion System for the spinal disorders | $685K | 169 mo ago | Seed | — | Lawrence Binder Founder | — | — | — |
| 32 | Non-Invasive Monitoring Systems Business coaching, consulting, and corporate training for expert business advice | $501K | 146 mo ago | Public | 1 | Jane Hsiao CEO & Chairman | — | — | — |
| 33 | Aurora BioPharma CAR T cell based immunotherapies for solid cancers. | $440K | 113 mo ago | Seed | — | Robert Brooks CEO | — | — | — |
| 34 | Avantyx Developer of preventative treatments for chemotherapy and diabetic peripheral neuropathy | $356K | 57 mo ago | Funding Raised | — | Bianca Ruiz Co-Founder & COO | — | — | — |
| 35 | Hansen Pharmaceutical Developer of gaseous nitric oxide to treat infections caused by antibiotic-resistant bacteria | $200K | 138 mo ago | Seed | — | Jeffrey L Jensen Co-Founder | — | — | — |
| 36 | Scion Cardio-Vascular Solutions for wound care and hemostasis | $200K | 177 mo ago | Early Stage | — | Louis Rose CEO | — | — | — |
| 37 | Epigenetix Pioneering epigenetic therapies for cancer, targeting novel drug discovery and development | $167K | 117 mo ago | Series A | — | Joseph Collard Cofounder CEO | — | 18 patents Pharmaceutical benzimidazole compounds and their controlled‑release formulations | — |
Top 12 Life Sciences companies in Miami
#1
Series B · Miami, Florida · founded 2009 · 24 employees$35.8Mraised▾
Developer of an AI-powered skin cancer detection device. The company offers DermaSensor device that uses a combination of cutting-edge optical spectroscopy and artificial intelligence to promptly analyze suspicious skin lesions. The device shines light bursts on a lesion, captures scattered light spectra, and uses proprietary AI algorithms to assess malignancy risk for melanoma, basal cell carcinoma, and squamous cell carcinoma.
- Oct 2025Series B$16M
- Nov 2024Series B$8.9M
- Jun 2022Series B$10M
- Dec 2021Series A$8.5M
#2
Series B · Miami, Florida · founded 2015 · 18 employees$30.6Mraised▾
Developer of live attenuated viral immunotherapeutic and prophylactic vaccine candidates. The company focuses on combating diseases resulting from herpes simplex virus infections. It aims to reduce suffering of those infected and reduce the spread of the virus. The goal is to revolutionize the treatment, prevention, and diagnosis of herpes and related diseases.
- Sep 2025Grant (prize money)$266.6K
- Apr 2025Grant (prize money)$291.5K
- Jan 2025Grant (prize money)$1.3M
- Aug 2023Grant (prize money)$1.3M
#3
Series A · Miami, Florida · founded 2013 · 4 employees$6.5Mraised▾
Developing extracellular vesicle therapies for debilitating rare diseases and dermatological disorders. The company pioneers regenerative medicine, utilizing extracellular vesicles (EVs) derived from mesenchymal stem cells (MSCs) to treat conditions with significant unmet medical needs. Their platform technology focuses on harnessing the regenerative, immunomodulatory, and anti-inflammatory potential of MSC-derived EVs. The company's approach involves cell-free therapies that deliver a natural biomolecular payload to treat disorders. Their patented EV harvesting technology allows for gentle isolation of EVs from MSCs. The lead product candidate targets dystrophic epidermolysis bullosa (DEB), addressing the protein collagen deficiency associated with the disease. The company's therapies aim to induce protein production, deliver essential cargo for tissue regeneration, reduce inflammation, accelerate healing, and improve overall cosmesis. This innovative approach has broad therapeutic potential in dermatology, immunology-based diseases, and protein deficient disorders.
- Dec 2025Conventional Debt$455.7K
- Jul 2020Series A$6.5M
#4
Funding Raised · Miami, Florida · founded 2023$3Mraised▾
Online retailer of nutritional supplements formulated for women's health needs. The company offers powder and gummy supplements designed to support gut health, digestion, energy, and skin. Products contain superfoods, prebiotics, probiotics, and adaptogens.
- Feb 2026Conventional Debt$3M
#5
Public · Miami, Florida · founded 2014 · 23 employees$1.1Mraised▾
Developer of cellular therapies for aging-related and life-threatening conditions. The company's product include Lomecel-B is derived from culture-expanded medicinal signaling cells harvested from the bone marrow of adult human donors. It is used for the treatment of aging frailty, Alzheimer’s disease, metabolic syndrome, acute respiratory distress syndrome, and hypoplastic left heart syndrome.
- Mar 2026Post IPO$15.9M
- Dec 2021Post IPO$20.5M
- Feb 2020Seed$100K
- Nov 2018Grant (prize money)$6.7M
#6
Series D · Miami, Florida · founded 2012 · 118 employees$179.4Mraised▾
Provider of robotic guidance system for dental surgeries. It is a computerized navigational system that assists both pre and intra-operative phases of dental implantation surgery. The device involves haptic robotic technology to provide physical guidance. It provides a haptic response to the dental surgeon’s hand for precise angulation during oral procedures.
- Jan 2024Series D$20M
- Oct 2022Series D$40M
- Oct 2020Series D$72M
- Jul 2019Series C$30M
#7
Funding Raised · Miami, Florida · founded 2015$1.9Mraised▾
Developing ligand-based therapies for neovascular diseases and cancer. The company pioneers a ligandomics technology to identify disease-specific cellular ligands as therapeutic targets. By modulating these ligands, they aim to create therapies with enhanced efficacy and reduced side effects. Their lead product is a therapeutic antibody targeting an angiogenic ligand upregulated in neovascular conditions, offering potential treatments for age-related macular degeneration, diabetic macular edema, and cancer. This innovative approach represents a significant advancement in targeted therapeutics, focusing on precision and improved patient outcomes. The company is focused on research and development in the biopharmaceutical sector.
- Feb 2025Grant (prize money)$256.6K
- Sep 2021Grant (prize money)$256.6K
- Jul 2020Grant (prize money)$224.7K
- Sep 2017Grant (prize money)$1.2M
#8
Series C · Miami, Florida · founded 2001 · 234 employees$110Mraised▾
Developer of regenerative biologic therapies for eye care. The company offers a range of products that aim to help improve patient outcomes in regenerative wound healing AmnioGraft, Prokera, Neox 1K, and more.
- Jun 2021Grant (prize money)$4.4M
- Apr 2019Series C$82.2M
- Nov 2016Grant (prize money)$4.4M
- Jun 2015Series B$15M
#9
Series A · Miami, Florida · founded 2022$12Mraised▾
Developer of a surgical device for treatment. It offers surgical robotic device for physicians to treat neurovascular diseases.
- Apr 2024Series A$12M
#10
Seed · Miami, Florida · founded 2021$10Mraised▾
Developer of metal-based therapies to treat neurological disorders. The company is involved in research and have developed a platform called PtS3-MetalloMix for metal speciation analysis. The company has developed pipeline of therapeutics for Parkinson's, Alzheimer's, Lewy Body Dementia, and Friedreich's Ataxia.
- Sep 2023Seed$10M
- Oct 2021Seed$1.2M
#11
Series A · Miami, Florida · founded 2021 · 3 employees$5Mraised▾
Developer of a medical device for temporary A-V sequential pacing catheter. It improves heart rhythm emergencies, cardiac surgeries, and interventional cardiology outcomes by re-establishing cardiac rhythm and improving heart output.
- Jan 2024Series A$1.5M
- May 2021Series A$3.5M
#12
Series B · Miami, Florida · founded 2021 · 2 employees$10.2Mraised▾
Developer of immunotherapies for neurological disorders. It offers a lead candidate Alhydrogel AD04 an immuno-stimulant that is used as an adjuvant in human and animal vaccination programs for the treatment of Alzheimer's disease.
- Jul 2023Series B$13.7M
Funding & investor landscape
Notable founders
Market landscape — 10 sub-themes by coverage
Share of Life Sciences coverage by sub-theme.
Regulatory-risk over time rising
Funding & growth over time
funding rising · growth rising
What Miami researches in biotechnology
University of Miami and affiliated medical centers lead Miami's biotech research, focusing on Alzheimer's treatments, gene therapy, and cancer immunology, with a cautiously optimistic tone amid growing recent output.
- University of Miami23
- Miami VA Healthcare System2
- Miami Transplant Institute1
- Miami University1
- Baptist Hospital of Miami1
Common questions
Riya reads income statements for fun. She covers the real money in a sector — revenue, growth, who actually earns — and never met a vague claim she didn't want a number for.